Hylartin V
Loading...Hylartin V Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not use in horses intended for human consumption.
HYLARTIN® V must not be administered intravascularly.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
HYLARTIN® V is a sterile pyrogen-free solution of a highly purified, specific fraction of the sodium salt of hyaluronic acid extracted from rooster combs. HYLARTIN® V is supplied in disposable glass syringes, each of which contains 20 mg (10 mg/mL) of sodium hyaluronate in 2.0 mL physiological sodium chloride-phosphate buffer with a pH of 7.0–7.5.
Sources
Hylartin V Manufacturers
-
Pharmacia & Upjohn Company
![Hylartin V (Hyaluronate Sodium) Injection [Pharmacia & Upjohn Company]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Hylartin V | Pharmacia & Upjohn Company
2 mL (20 mg) of HYLARTIN® V given to horses intra-articularly in small and medium size joints (carpal, fetlock). In the treatment of larger joints (hock), the dosage is 4 mL (40 mg). The treatment may be repeated at weekly intervals for a total of three treatments.
HYLARTIN® V should be injected in horses intra-articularly under strict aseptic conditions. Effusion should be removed prior to injection. When performing the injections, care should be taken not to scratch the cartilage surface, as this may result in diffuse swelling lasting for 24 to 48 hours. This transient swelling, however, will have no effect on the ultimate clinical result. For best results, the horse should be given two days stall rest before gradually resuming normal activity.
-
Zoetis Inc.
Hylartin V | Zoetis Inc.
DOSAGE AND ADMINISTRATION:
2 mL (20 mg) of HYLARTIN® V given to horses intra-articularly in small and medium size joints (carpal, fetlock). In the treatment of larger joints (hock), the dosage is 4 mL (40 mg). The treatment may be repeated at weekly intervals for a total of three treatments.
HYLARTIN® V should be injected in horses intra-articularly under strict aseptic conditions. Effusion should be removed prior to injection. When performing the injections, care should be taken not to scratch the cartilage surface, as this may result in diffuse swelling lasting for 24 to 48 hours. This transient swelling, however, will have no effect on the ultimate clinical result. For best results, the horse should be given two days stall rest before gradually resuming normal activity.
![Hylartin V (Hyaluronate Sodium) Injection [Zoetis Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0b7e0ce8-f606-430f-8174-5dfd42e7a94f&name=hylartin-06.jpg)
Login To Your Free Account